Abstracts Archive - Page 1342 of 2607 - ACR Meeting Abstracts

Abstract Number: 2337 • 2018 ACR/ARHP Annual Meeting
Vertebral Compression Fractures and Antibodies to Citrullinated Vimentin in Established Rheumatoid Arthritis
Jonathan Cheah^1,2, John A. Carrino^3,4, William H. Robinson^5,6, Dana Orange^7,8, Jackie Szymonifka⁹, Emily M. Stein^1,2 and Susan M. Goodman^9,10, ¹Medicine, Hospital for Special Surgery, New York, NY, ²Medicine, Weill Cornell Medicine, New York, NY, ³Radiology, Hospital for Special Surgery, New York, NY, ⁴Radiology, Weill Cornell Medicine, New York, NY, ⁵VA Palo Alto Health Care System, Palo Alto, CA, ⁶Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, ⁷Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Rockefeller University, New York, NY, ⁹Hospital for Special Surgery, New York, NY, ¹⁰Rheumatology, Weill Cornell Medicine, New York, NY
Background/Purpose: Patients with RA have high rates of osteoporosis and fractures and RA induces articular and extra-articular bone loss. Seropositivity for any CCP antibody is…
Abstract Number: 2338 • 2018 ACR/ARHP Annual Meeting
Pharmacological and Non-Pharmacological Approaches in a Group of Osteoporotic Patients Referring to a Rehabilitation out-Patient Clinic
Pinar Borman¹, ESRA GIZEM KOYUNCU¹, Aysegul Yaman¹ and MERVE PARLAK², ¹University of Hacettepe Faculty of Medicine, Dept of PMR, Ankara, Turkey, ²University of Hacettepe Faculty of Medicine, Dept of Public Health, Ankara, Turkey
Background/Purpose: Non-pharmacologic treatments are generally kept in the background in management of osteoporosis. The aim of this retrospective study was to evaluate characteristics and frequency…
Abstract Number: 2339 • 2018 ACR/ARHP Annual Meeting
The Patient’s Perspective of Glucocorticoid Use: A Systematic Literature Review of Quantitative and Qualitative Studies
Jonathan Cheah^1,2, Joanna Robson^3,4, Rachel Black^5,6, Susan M. Goodman^7,8, Susan Lester^9,10, Sarah Mackie¹¹ and Catherine Hill^6,12, ¹Medicine, Hospital for Special Surgery, New York, NY, ²Medicine, Weill Cornell Medicine, New York, NY, ³Faculty of Health and Applied Science, University of the West of England, Bristol, United Kingdom, ⁴School of Clinical Sciences, University of Bristol, Bristol, United Kingdom, ⁵Rheumatology, Royal Adelaide Hospital, Adelaide, Australia, ⁶Medicine, The University of Adelaide, Adelaide, Australia, ⁷Rheumatology, Weill Cornell Medicine, New York, NY, ⁸Hospital for Special Surgery, New York, NY, ⁹Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, ¹⁰Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, ¹¹NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ¹²The Queen Elizabeth Hospital, Adelaide, Australia
Background/Purpose: Glucocorticoids (GCs) remain widely used and have well documented adverse effects. However, the impact of these adverse effects from the perspective of the patient,…
Abstract Number: 2340 • 2018 ACR/ARHP Annual Meeting
The Impact of Chronic Glucocorticoid Use Amongst Patients with Rheumatoid Arthritis: A Qualitative Study
Jonathan Cheah^1,2, Sarah Young³, Susan M. Goodman^4,5, Catherine Hill^6,7, Susan Beard⁸, Pamela Richards⁹, Sarah Mackie¹⁰, Joanna Robson^11,12 and Iris Navarro-Millán^5,13, ¹Medicine, Hospital for Special Surgery, New York, NY, ²Medicine, Weill Cornell Medicine, New York, NY, ³Binghamton University, Binghamton, NY, ⁴Rheumatology, Weill Cornell Medicine, New York, NY, ⁵Hospital for Special Surgery, New York, NY, ⁶The Queen Elizabeth Hospital, Adelaide, Australia, ⁷Medicine, The University of Adelaide, Adelaide, Australia, ⁸Patient Research Partner, Adelaide, Australia, ⁹Patient Research Partner, Bristol, United Kingdom, ¹⁰NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ¹¹Faculty of Health and Applied Science, University of the West of England, Bristol, United Kingdom, ¹²School of Clinical Sciences, University of Bristol, Bristol, United Kingdom, ¹³Weill Cornell Medicine, New York, NY
Background/Purpose: Glucocorticoids (GCs) have well documented adverse effects. However, the absolute risk and importance of these effects have not been well documented from the perspective…
Abstract Number: 2341 • 2018 ACR/ARHP Annual Meeting
A Link between Quality of Patient–Rheumatologist Communication and Patient Healthcare Needs in Psoriatic Arthritis: An Online Survey of US-Based Patients and Rheumatologists
Ana-Maria Orbai¹, Laura C. Coates², Valderilio F Azevedo³, Amit Garg⁴, Amar Majjhoo⁵, Christopher E M Griffiths⁶, Pamela Young⁷, Joseph C Cappelleri⁸, Jade Moser⁹ and Lara Fallon¹⁰, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²University of Oxford, Oxford, United Kingdom, ³Universidade Federal do Paraná, Curitiba, Brazil, ⁴Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, ⁵Shores Rheumatology, St Clair Shores, MI, ⁶Dermatology Centre, University of Manchester, Manchester, United Kingdom, ⁷Pfizer Inc, Collegeville, PA, ⁸Pfizer Inc, Groton, CT, ⁹The Harris Poll, Rochester, NY, ¹⁰Pfizer Canada, Montreal, QC, Canada
Background/Purpose: Patient (pt)–rheumatologist (rheum) communication may influence symptom reporting and disease control in psoriatic arthritis (PsA). This online survey evaluated pt–rheum communication and assessed PsA…
Abstract Number: 2342 • 2018 ACR/ARHP Annual Meeting
A Pan-Canadian Study of Factors Associated with Perceived Doctor-Patient Communication in Patients with Systemic Lupus Erythematosus
Deborah Da Costa¹, Carolyn Neville², Anne-Sophie Julien³, Murray Rochon⁴, Davy Eng⁵, Christine A. Peschken⁶, Evelyne Vinet⁷, C Douglas Smith⁸, Mark Matsos⁹, Janet E. Pope¹⁰, Ann E. Clarke¹¹, Stephanie Keeling¹², J. Antonio Avina-Zubieta¹³, Marie Hudson¹⁴ and Paul R. Fortin¹⁵, ¹Medicine, McGill University, Montreal, QC, Canada, ²Department of Medicine, McGill University Health Center, Montreal, QC, Canada, ³CHU de Québec - Université Laval, Quebec City, QC, Canada, ⁴Jack Digital, Toronto, ON, Canada, ⁵Centre de recherche du CHU de Québec, Université Laval, Québec, QC, Canada, ⁶RR 149G, University of Manitoba, Winnipeg, MB, Canada, ⁷Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁸The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ⁹Medicine, McMaster University, Hamilton, ON, Canada, ¹⁰Department of Medicine, University of Western Ontario, London, ON, Canada, ¹¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ¹²Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, ¹³Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁴Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, ¹⁵Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with fluctuating levels of disease activity, which may require frequent encounters with the medical system…
Abstract Number: 2343 • 2018 ACR/ARHP Annual Meeting
Exploring Decision Making Needs about Pain Management Among Adolescents with Juvenile Idiopathic Arthritis and Their Families: Preliminary Results from Interviews
Karine Toupin-April¹, Jennifer N. Stinson², Adam Huber^3,4, Ciarán M. Duffy⁵, Isabelle Gaboury⁶, Esi Morgan^7,8, Lucie Brosseau⁹, William Brinkman^7,8, Linda Li¹⁰, Tania El Hindi¹¹, Aditi Sivakumar¹¹, Marg Bisch¹², Janice Cohen¹³, Elizabeth Stringer¹⁴, France Légaré¹⁵, Laurie Proulx¹⁶, Paul R. Fortin¹⁷ and Peter Tugwell¹⁸, ¹Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, ²Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, ³IWK Health Centre, Halifax, NS, Canada, ⁴Dalhousie University, Halifax, NS, Canada, ⁵Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁶Universite de Sherbrooke, Sherbrooke, ON, Canada, ⁷Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸University of Cincinnati, Cincinnati, OH, ⁹University of Ottawa, Ottawa, ON, Canada, ¹⁰Arthritis Research Canada, Richmond, BC, Canada, ¹¹Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, ¹²Children's Hospital of Eastern Ontario, Ottawa, ON, Canada, ¹³Children's Hospital of Eastern Ontario Research Institute, ottawa, ON, Canada, ¹⁴Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, ¹⁵Laval University, Montreal, QC, Canada, ¹⁶Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, ¹⁷Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada, ¹⁸Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada
Background/Purpose: Adolescents with juvenile idiopathic arthritis (JIA), one of the most common causes of chronic musculoskeletal pain among youth, face many difficult decisions. However, we…
Abstract Number: 2344 • 2018 ACR/ARHP Annual Meeting
Treatment Modes in Rheumatoid Arthritis: Moving Toward Shared Decision-Making
Peter C. Taylor¹, Neil Betteridge², T Michelle Brown³, John Woolcott⁴, Alan J. Kivitz⁵, Cristiano A F Zerbini⁶, Diane Whalley⁷, Oyebimpe Olayinka-Amao³, Connie Chen⁸, Palle Dahl⁹, Dario Ponce de Leon¹⁰, David Gruben¹¹ and Lara Fallon¹², ¹University of Oxford, Oxford, United Kingdom, ²Neil Betteridge Associates, London, United Kingdom, ³RTI Health Solutions, Research Triangle Park, NC, ⁴Pfizer Inc, Collegeville, PA, ⁵Altoona Center for Clinical Research, Duncansville, PA, ⁶Centro Paulista de Investigação Clinica, São Paulo, Brazil, ⁷RTI Health Solutions, Manchester, United Kingdom, ⁸Pfizer Inc, New York, NY, ⁹Pfizer Inc, Ballerup, Denmark, ¹⁰Pfizer Inc, Lima, Peru, ¹¹Pfizer Inc, Groton, CT, ¹²Pfizer Canada, Montreal, QC, Canada
Background/Purpose: Treatment recommendations in RA emphasize shared decision-making,1 but little is known about patient (pt) perspectives. Through qualitative research, we aim to understand pt preferences…
Abstract Number: 2345 • 2018 ACR/ARHP Annual Meeting
Systematic Review of Patient Decision Aids for Chronic Musculoskeletal Pain
Rabih Nayfe¹, Emily Bowen², Nathaniel Milburn², Helen Mayo², Ethan Halm², MC. Reid³, Liana Fraenkel⁴ and Una E. Makris⁵, ¹Department of Medicine, UT Southwestern Medical Center, Dallas, TX, ²UT Southwestern Medical Center, Dallas, TX, ³Weill Cornell Medicine, New York, NY, ⁴Yale University School of Medicine, New Haven, CT, ⁵UT Southwestern Medical Center and Dallas VA, Dallas, TX
Background/Purpose: Chronic musculoskeletal (MSK) pain is common and disabling; it is among the top reasons for doctor’s visits in the US. Most treatment decisions for…
Abstract Number: 2346 • 2018 ACR/ARHP Annual Meeting
Emerging Ethical Issues in Physical Activity Monitoring of Persons Living with Arthritis: A Qualitative Evidence Synthesis
Jenny Leese^1,2, Siyi Zhu^2,3,4, Graham Macdonald^2,5, Mir-Masoud Pourrahmat^2,3, Anne F. Townsend^6,7, Catherine L. Backman^8,9, Laura Nimmon³ and Linda Li^2,10, ¹Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ²Arthritis Research Canada, Richmond, BC, Canada, ³University of British Columbia, Vancouver, BC, Canada, ⁴Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, China, ⁵Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ⁶Qualitative Research, Arthritis Research Canada, Richmond, BC, Canada, ⁷University of Exeter Medical School, University of Exeter, exeter, United Kingdom, ⁸Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, ⁹Occupational Science & Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ¹⁰Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Although physical activity is a key component of optimal arthritis self-management, levels of physical activity typically fall below expert recommendations among persons with arthritis.[1]…
Abstract Number: 2347 • 2018 ACR/ARHP Annual Meeting
Effectiveness of Shared Decision Making in Systemic Lupus Erythematosus Patients at OSU
Juliette Yedimenko¹, Paige Hackenberger², Emily Sullivan³, Kelly Morris⁴ and Alexa Meara⁵, ¹The Ohio State University Wexner Medical Center, Columbus, OH, ²The Ohio State University School of Medicine, Columbus, OH, ³The Ohio State Univeristy Wexner Medical Center, Columbus, OH, ⁴Rheumatology and Immunology, The Ohio State University, Columbus, OH, ⁵Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH
Background/Purpose: Patient autonomy is an integral part of the treatment process. For effective shared decision making (SDM) patients must fully understand their disease process, prognosis…
Abstract Number: 2348 • 2018 ACR/ARHP Annual Meeting
Prescriber Attitudes and Beliefs about Triple Therapy for Patients with Rheumatoid Arthritis: Knowledge Exchange in Internet Forums and Social Media
Maria A. Lopez-Olivo¹, Jude K. A. des Bordes¹, Gregory Pratt² and Maria Suarez-Almazor¹, ¹Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, ²Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX
Background/Purpose: Several forums on the internet serve as repositories of personal experiences and exchange of health information. Online discussions among healthcare providers about management of…
Abstract Number: 2349 • 2018 ACR/ARHP Annual Meeting
“I Was Prepared for the Other Side Effects; I Wasn’t Prepared for This One.”: A Qualitative Study of the Patients’ Experience of Inflammatory Arthritis Due to Immune Checkpoint Inhibitor Therapy for Cancer
Laura C. Cappelli¹, Suzanne Grieb², Ana-Maria Orbai³, Ami A. Shah¹ and Clifton O. Bingham III⁴, ¹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Johns Hopkins Bayview Medical Center, Center for Child and Community Health Research, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Patients treated for cancer with immune checkpoint inhibitors (ICI) can develop a variety of adverse events. Inflammatory arthritis (IA) is an increasingly recognized event…
Abstract Number: 2350 • 2018 ACR/ARHP Annual Meeting
Examining Ethnic Differences in Osteoarthritis (OA) Patients’ Knowledge and Attitudes Regarding Prescription Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Hana Masood¹, Michael J. Hannon², C. Kent Kwoh¹, Jazmin Dagnino³ and Ernest Vina⁴, ¹Medicine, Division of Rheumatology, University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ, ²Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ³University of Arizona Arthritis Center, Tucson, AZ, ⁴University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ
Background/Purpose: NSAIDs are commonly prescribed for the treatment of OA. While there are documented differences between Hispanics and non-Hispanic whites (NHWs) in their treatment preferences…
Abstract Number: 2351 • 2018 ACR/ARHP Annual Meeting
Attitudes Toward Telehealth Video Conferencing Among Patients with Rheumatic Disease
Dawen Zhang^1,2, Jennifer Lu², Cleopatra Aquino- Beaton², Nancy Harada² and Meika A. Fang^1,2, ¹UCLA Dept of Medicine, Division of Rheumatology, Los Angeles, CA, ²VA Greater Los Angeles Healthcare System, Los Angeles, CA
Background/Purpose: Video Teleconferencing (VTC) telehealth is a synchronous medium in which patients may interact with physicians using their own personal electronic device or at a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].